Delivery Order SPE2DB24D6044-SPE2DB25FLJJM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,089.30 to AmerisourceBergen Drug Corp for the supply of Chlorhexidine 0.12% in 15 milliliter unit-dose cups. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a $2,748.51 delivery order to AmerisourceBergen Drug Corp for the supply of Chlorhexidine 0.12% Rinse in 473ml quantities. This competitive award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price transaction with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Chlorhexidine 0.12% Rinse 473ML. The $1,171.76 Firm Fixed Price contract has an ultimate completion date of July 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,169.99 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award is being fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, and the specific...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,279.88 to AmerisourceBergen Drug Corp on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare procurement needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under its existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at the company's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $152,556.74 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price, competitively awarded delivery order (Contract No. 4569202619) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The order is to be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,724.96 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA and carries no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJJMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Chlorhexidine 0.12% in 15 milliliter unit dose cups, with a ceiling value of $1,526.10 and ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under the company's broader contract vehicles with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/20/25 |